Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||Bisphosphonate-associated osteonecrosis of the external auditory canal|
|Citation:||Journal of Laryngology and Otology, 2013; 127(S2):51-53|
|Publisher:||Headley Brothers Ltd|
|N Wickham, A Crawford, A S Carney, A N Goss|
|Abstract:||BACKGROUND: Osteonecrosis is a benign condition characterised by necrotic exposed bone, and is associated with bisphosphonate use. Osteonecrosis of the external auditory canal is rare, with only a few reported cases. METHOD: Two case reports of temporal bone osteonecrosis are presented. RESULTS: A 64-year-old man with a history of immunoglobulin G kappa multiple myeloma developed a right external auditory canal ulcer 6 years after commencement on clodronate. A 72-year-old woman taking alendronate for osteoporosis, initially diagnosed and treated for right-sided otitis externa, was found to have underlying exposed bone in the right external auditory canal, with a computed tomography scan confirming destruction of the temporal bone. CONCLUSION: With increasing use of both oral and intravenous bisphosphonates in the community for benign conditions such as osteoporosis and for malignant conditions such as breast cancer and multiple myeloma, the diagnosis of bisphosphonate-associated osteonecrosis should always be considered in patients with a temporal bone lesion, and a relevant drug history taken.|
|Keywords:||Bone Diseases; Bisphosphonates; Osteonecrosis; Jaw; Ear Canal; Temporal Bone|
|Rights:||Copyright © JLO (1984) Limited 2013|
|Appears in Collections:||Dentistry publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.